Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference47 articles.
1. Vanderkoo OG, Gregson DB, Kellner JD, Laupland KB. Staphylococcus aureus bloodstream infections in children: a population-based assessment. Paediatr Child Health. 2011;16(5):276–80.
2. Suryati B, Watson M. Staphylococcus aureus bacteraemia in children: a 5-year retrospective review. J Paediatr Child Health. 2002;38(3):290–4.
3. •• McMullan BJ, Campbell AJ, Blyth CC, McNeil JC, Montgomery CP, Tong SYC, et al. Clinical management of Staphylococcus aureus bacteremia in neonates, children, and adolescents. Pediatrics. 2020;146(3):e20200134. Findings showed the different presentations and risk factors for MRSA bacteremia. It was discussed that in pediatrics, a large cohort of patients with SA bacteremia are healthy children with no medical problems which is different from adults.
4. •• Kaplan SL. Methicillin-resistant Staphylococcus aureus infections in children: epidemiology and clinical spectrum [Internet]. 2021. Available from: https://www.uptodate.com/contents/methicillin-resistant-staphylococcus-aureus-infections-in-children-epidemiology-and-clinical-spectrum/print?topicRef=6025&so…1/26OfficialreprintfromUpToDatewww.uptodate.com. Accessed 21 Nov 2021. This paper discussed the updated geographical differences along with recent incidence and prevalence of MRSA. Furthermore, updated definitions for hospital and community onset were established. Key points regarding pathogenesis and clinical spectrum of MRSA were reported. Since rates of resistance are increasing and MRSA is no longer only a nosocomial infection, it is Important for clinicians in the community to be aware of the alternative risk factors and high risk populations.
5. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus : epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616–87.